{"id":"5f02cb88-8b08-5bda-90f9-1c8617c67156","stable_key":"4fef8d72-f107-5eb5-b2fb-483ca85465e0:k2-fsp1-loss","predicate":"loss_reduces_mk4_protection_against","statement":"FSP1 knockout diminished MK-4 and K1 protection; wild-type FSP1 rescued protection while its myristoylation-defective G2A mutant did not.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"60e093f5-7ff5-5934-931e-4acb05735fc5","mechanism_event_label":"Providing the quinone did not fully substitute for an appropriately located working reductase.","subject":{"id":"6c60c705-b3dc-548d-a2ad-e9f75249a642","slug":"aifm2","display_name":"FSP1 / AIFM2","entity_type_key":"protein"},"object":{"id":"85ca0bb8-8a67-59fe-8334-e0f6617380b7","slug":"ferroptosis","display_name":"Ferroptosis","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"60e093f5-7ff5-5934-931e-4acb05735fc5","stable_key":"4fef8d72-f107-5eb5-b2fb-483ca85465e0:k2-fsp1-loss-event","event_type":"biochemical_relationship","label":"Providing the quinone did not fully substitute for an appropriately located working reductase.","description":"FSP1 knockout diminished MK-4 and K1 protection; wild-type FSP1 rescued protection while its myristoylation-defective G2A mutant did not.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"5155b9d1-e835-54b4-9f61-4cf35b3e5227","slug":"menaquinone-4","display_name":"Menaquinone-4 / MK-4 / menatetrenone","entity_type_key":"small_molecule"},"role":"tested_form","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"5f9fd13b-5428-5024-a855-9db526855890","slug":"phylloquinone","display_name":"Phylloquinone","entity_type_key":"small_molecule"},"role":"other_tested_form","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"6c60c705-b3dc-548d-a2ad-e9f75249a642","slug":"aifm2","display_name":"FSP1 / AIFM2","entity_type_key":"protein"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"85ca0bb8-8a67-59fe-8334-e0f6617380b7","slug":"ferroptosis","display_name":"Ferroptosis","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/k2-research/35922516.fulltext.txt\", \"locator\": \"Exact primary full-text span; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"a75e4881732cbe87173197db393b42d49fc6e8110df919fed8d63b16c9877da6\", \"start_char\": 15449, \"end_char\": 16082, \"text_sha256\": \"689a74e99dd668d48baef5232109dbf2898ba3adca2999a83a7bb24b321420c0\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Enzyme/liposome chemistry, knockout cells and warfarin-exposed mice","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"MK-4/K1, NAD(P)H, FSP1 loss and inhibitors","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Preclinical experiments; not a demonstrated oral MK-7 treatment for ferroptosis-related disease or a self-treatment regimen for anticoagulant poisoning.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Vitamin K2 research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"k2","display_name":"Vitamin K2 / menaquinone family","entity_type_key":"chemical_species"}},{"dimension":"organism","value_text":"Human recombinant FSP1, mammalian cells and mice","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Providing the quinone did not fully substitute for an appropriately located working reductase.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[k2-p35922516] A non-canonical vitamin K cycle is a potent ferroptosis suppressor. (2022). https://pubmed.ncbi.nlm.nih.gov/35922516/ DOI: 10.1038/s41586-022-05022-3","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Lipid peroxidation and vitamin K reduction","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"f868cd0a-27be-503b-a0c9-1a9e18831d0b","evidence_kind":"source_excerpt","locator":"Lines 799-810","start_line":799,"end_line":810,"excerpt":"### k2-fsp1-loss\nFSP1 knockout diminished MK-4 and K1 protection; wild-type FSP1 rescued protection while its myristoylation-defective G2A mutant did not.\nCondition category: machinery_impairment\nnutrient_topic: Vitamin K2 research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: Providing the quinone did not fully substitute for an appropriately located working reductase.\norganism: Human recombinant FSP1, mammalian cells and mice\ntissue_or_cell_type: Lipid peroxidation and vitamin K reduction\nexperimental_model: Enzyme/liposome chemistry, knockout cells and warfarin-exposed mice\nlimitations: Preclinical experiments; not a demonstrated oral MK-7 treatment for ferroptosis-related disease or a self-treatment regimen for anticoagulant poisoning.\nexposure: MK-4/K1, NAD(P)H, FSP1 loss and inhibitors\nevidence_span: {\"source_cache\": \"artifacts/k2-research/35922516.fulltext.txt\", \"locator\": \"Exact primary full-text span; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"a75e4881732cbe87173197db393b42d49fc6e8110df919fed8d63b16c9877da6\", \"start_char\": 15449, \"end_char\": 16082, \"text_sha256\": \"689a74e99dd668d48baef5232109dbf2898ba3adca2999a83a7bb24b321420c0\"}\n[k2-p35922516] A non-canonical vitamin K cycle is a potent ferroptosis suppressor. (2022). https://pubmed.ncbi.nlm.nih.gov/35922516/ DOI: 10.1038/s41586-022-05022-3","model_system":"Enzyme/liposome chemistry, knockout cells and warfarin-exposed mice","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [k2-p35922516] A non-canonical vitamin K cycle is a potent ferroptosis suppressor. (2022). https://pubmed.ncbi.nlm.nih.gov/35922516/ DOI: 10.1038/s41586-022-05022-3","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"dfeae572-af3d-5042-a10e-e67596f9ab28","stable_key":"import-4fef8d72-f107-5eb5-b2fb-483ca85465e0","title":"Vitamin K2: menaquinone forms, carboxylation, recycling and nutrient interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"dc31aff21110d09b025c177e03b4c5ca8349d52bf5f962285fdbfcf660c0e4f6","revision_id":"850887db-34f6-55aa-9d3e-b8fd3a4a5de3","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}